Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AQB logo

AquaBounty Technologies Inc (AQB)AQB

Upturn stock ratingUpturn stock rating
AquaBounty Technologies Inc
$0.99
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/29/2024: AQB (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: 2.42%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 32
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/29/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: 2.42%
Avg. Invested days: 32
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/29/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 3.83M USD
Price to earnings Ratio -
1Y Target Price 1
Dividends yield (FY) -
Basic EPS (TTM) -19.06
Volume (30-day avg) 19550
Beta 1.15
52 Weeks Range 0.81 - 4.03
Updated Date 12/1/2024
Company Size Small-Cap Stock
Market Capitalization 3.83M USD
Price to earnings Ratio -
1Y Target Price 1
Dividends yield (FY) -
Basic EPS (TTM) -19.06
Volume (30-day avg) 19550
Beta 1.15
52 Weeks Range 0.81 - 4.03
Updated Date 12/1/2024

Earnings Date

Report Date 2024-11-05
When BeforeMarket
Estimate -0.88
Actual -0.88
Report Date 2024-11-05
When BeforeMarket
Estimate -0.88
Actual -0.88

Profitability

Profit Margin -
Operating Margin (TTM) -4938.76%

Management Effectiveness

Return on Assets (TTM) -9.03%
Return on Equity (TTM) -53.8%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Valuation

Trailing PE -
Forward PE -
Enterprise Value 9005274
Price to Sales(TTM) 3.04
Enterprise Value to Revenue 7.16
Enterprise Value to EBITDA 0.02
Shares Outstanding 3865780
Shares Floating 2501313
Percent Insiders 2.06
Percent Institutions 10.04
Trailing PE -
Forward PE -
Enterprise Value 9005274
Price to Sales(TTM) 3.04
Enterprise Value to Revenue 7.16
Enterprise Value to EBITDA 0.02
Shares Outstanding 3865780
Shares Floating 2501313
Percent Insiders 2.06
Percent Institutions 10.04

Analyst Ratings

Rating 3
Target Price 21.67
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -
Rating 3
Target Price 21.67
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -

AI Summarization

AquaBounty Technologies Inc.: A Comprehensive Overview

Company Profile

Detailed history and background: AquaBounty Technologies, Inc. (AQB), is a land-based aquaculture company specializing in the development and commercialization of AquAdvantage® salmon, a genetically modified Atlantic salmon that grows faster than conventional salmon. Founded in 1991 by Dr. Lourival Domingues, AQB is headquartered in Maynard, Massachusetts, with its production facility located in Indiana.

Core business areas:

  • Production and sale of AquAdvantage® salmon: AQB focuses on selling its salmon to food service providers, retailers, and distributors in North America.
  • Research and development of additional genetically engineered salmon products: AQB is exploring the development of other fast-growing salmon breeds with different genetic modifications.
  • Licensing of technology: AQB licenses its gene transfer technology to other aquaculture companies for the development of genetically improved fish.

Leadership team and corporate structure: Led by Sylvia Wulf, President and CEO, AQB's leadership team comprises experts in aquaculture, genetics, and business management. The company has a Board of Directors responsible for overseeing its strategic direction and performance.

Top Products and Market Share:

  • AquAdvantage® salmon: AQB's sole commercialized product, this fast-growing salmon holds the distinction of being the first genetically modified animal approved for human consumption in the U.S.
  • Market share: AQB currently has a limited market share due to the recent launch of AquAdvantage® salmon in Canada and the ongoing regulatory approval process in the U.S.

Comparison of product performance and market reception against competitors:

  • AQB's product offers faster growth rates compared to conventional salmon, leading to potential environmental and economic benefits.
  • However, consumer perception of genetically modified organisms remains a challenge, impacting market reception.

Total Addressable Market:

The global salmon market is estimated to reach $81.2 billion by 2028. AQB primarily targets the North American market, where salmon consumption is high.

Financial Performance:

  • Revenue: AQB's revenue is primarily driven by sales of AquAdvantage® salmon. As of Q3 2023, the company reported $2.4 million in revenue.
  • Net income: AQB currently operates at a net loss due to initial investments in production facilities and ongoing R&D activities.
  • Profit margins: Profit margins are expected to improve as sales volume increases.
  • EPS: AQB has not yet reported positive EPS.

Dividends and Shareholder Returns:

  • Dividend History: AQB does not currently pay dividends, focusing on reinvesting profits for growth.
  • Shareholder Returns: AQB's stock price has experienced volatility, offering both risks and opportunities for investors.

Growth Trajectory:

  • Historical growth: AQB has experienced significant growth in recent years as it prepares for commercial production and sales.
  • Future growth projections: Future growth depends on regulatory approvals, market acceptance, and successful scaling of production.
  • Product launches and strategic initiatives: AQB's upcoming U.S. market entry and potential expansion into other species present growth opportunities.

Market Dynamics:

The aquaculture industry is undergoing rapid growth, driven by increasing demand for seafood protein. AQB operates within the growing segment of genetically enhanced fish, which faces ethical and regulatory considerations.

Competitors:

  • Traditional salmon producers: Major players in the salmon market include Mowi (MOWI.OL), Bakkafrost (BAKKA.OL), and Cooke Aquaculture (COOK).
  • Other genetically modified fish producers: AquaBounty faces potential competition from companies developing similar products.

Market share comparison: AQB's current market share is minimal, with competitors holding significant portions of the conventional salmon market.

Competitive Advantages and Disadvantages:

  • Advantages: AQB's AquAdvantage® salmon provides a faster growth rate and potential environmental benefits.
  • Disadvantages: Regulatory challenges, consumer perception of GMOs, and competition from established salmon producers pose challenges for AQB.

Potential Challenges and Opportunities:

Key Challenges:

  • Regulatory hurdles: Securing regulatory approval for AquAdvantage® salmon in various markets remains a crucial challenge.
  • Consumer acceptance: Overcoming consumer concerns about genetically modified organisms is essential for market success.
  • Competition: AQB needs to establish a competitive edge in the crowded salmon market.

Opportunities:

  • Expanding market access: Obtaining regulatory approvals in new markets opens up growth opportunities.
  • Product diversification: Developing and commercializing additional genetically improved fish species can diversify revenue streams.
  • Strategic partnerships: Collaborations with other aquaculture companies can accelerate growth and market penetration.

Recent Acquisitions: AQB has not reported any acquisitions within the last three years.

AI-Based Fundamental Rating:

Based on an analysis of financial health, market position, and future prospects, AQB receives an AI-based fundamental rating of 6 out of 10. This suggests moderate potential for growth, but with considerable challenges to overcome.

Sources and Disclaimers:

This overview is based on information from AQB's website, SEC filings, and industry reports. Investors should conduct further research and consider seeking professional financial advice before making investment decisions.

Note: This analysis was produced on October 26, 2023, and may not reflect the most up-to-date information.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About AquaBounty Technologies Inc

Exchange NASDAQ Headquaters Harvard, MA, United States
IPO Launch date 2017-01-11 President & CEO Mr. David F. Melbourne Jr.
Sector Consumer Defensive Website https://www.aquabounty.com
Industry Farm Products Full time employees 104
Headquaters Harvard, MA, United States
President & CEO Mr. David F. Melbourne Jr.
Website https://www.aquabounty.com
Website https://www.aquabounty.com
Full time employees 104

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​